Lung Neoplasms: all 7,334 studies
Page 22 of 74. Open to participants first (1,555), then studies with results posted, then the rest; newest registration first within each.
- Maintenance Chemotherapy Versus Consolidative Stereotactic Body Radiation Therapy (SBRT) Plus Maintenance Chemotherapy for Stage IV Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II TrialCompletedNCT02045446Phase 2Results posted
- An Open-Label, Randomized, Phase 3 Trial of Nivolumab Versus Investigator's Choice Chemotherapy as First-Line Therapy for Stage IV or Recurrent PD-L1+ Non-Small Cell Lung Cancer (CheckMate 026)CompletedNCT02041533Phase 3Results posted
- LDK378 in Adult Chinese Patients With ALK-rearranged (ALK-positive) Advanced Non-small Cell Lung Cancer (NSCLC) Previously Treated With CrizotinibCompletedNCT02040870Phase 1/2Results posted
- A Study of Pembrolizumab (MK-3475) in Combination With Chemotherapy or Immunotherapy in Participants With Non-small Cell Lung Cancer (MK-3475-021/KEYNOTE-021)CompletedNCT02039674Phase 1/2Results posted
- Phase 2 Study of Alisertib (MLN8237) in Combination With Paclitaxel Versus Placebo in Combination With Paclitaxel as Second Line Therapy for Small Cell Lung Cancer (SCLC)CompletedNCT02038647Phase 2Results posted
- Investigation of GSK2879552 in Subjects With Relapsed/Refractory Small Cell Lung CarcinomaTerminatedNCT02034123Phase 1Results posted
- A Study of Atezolizumab in Participants With Programmed Death - Ligand 1 (PD-L1) Positive Locally Advanced or Metastatic Non-Small Cell Lung CancerCompletedNCT02031458Phase 2Results posted
- Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung CancerCompletedNCT02027428Phase 3Results posted
- Metformin and Carbohydrate Restriction With Platinum Based Chemotherapy In Stage IIIB/IV Non-Squamous Non-Small Cell Lung Cancer (NS-NSCLC)TerminatedNCT02019979Phase 2Results posted
- Prognostic Value of Tumor Hypoxia, as Measured by 18F-FMISO Breath Hold PET/CT, in Non-Small-Cell-Lung Cancer (NSCLC) PatientsCompletedNCT02016872Not applicableResults posted
- A Study of Tarceva (Erlotinib) in Patients With Advanced Non-Small Cell Lung Cancer Naive to ChemotherapyCompletedNCT02013206Phase 2Results posted
- A Study of Atezolizumab Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum-Containing TherapyCompletedNCT02008227Phase 3Results posted
- Study of Pembrolizumab (MK-3475) in Participants With Advanced Non-small Cell Lung Cancer (MK-3475-025/KEYNOTE-025)CompletedNCT02007070Phase 1Results posted
- Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)CompletedNCT01999985Phase 1Results posted
- A Study of Tarceva (Erlotinib) in Combination With Platinum Based Chemotherapy in Patients With Non-Small Cell Lung Cancer.CompletedNCT01998919Phase 2Results posted
- A Study of Tarceva (Erlotinib) Monotherapy in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)CompletedNCT01996332Phase 2Results posted
- A Study to Assess the Survival of Non-small Cell Lung Cancer Patients Treated With Tarceva After Failed Chemotherapy TreatmentTerminatedNCT01990261Results posted
- Phase 1b/2 Study of Carfilzomib, Carboplatin, and Etoposide in Patients With Previously Untreated Extensive Stage Small-cell Lung CancerCompletedNCT01987232Phase 1/2Results posted
- A Study Of PF-06463922 An ALK/ROS1 Inhibitor In Patients With Advanced Non Small Cell Lung Cancer With Specific Molecular AlterationsCompletedNCT01970865Phase 1/2Results posted
- Efficacy and Safety Study of ABP 215 Compared With Bevacizumab in Patients With Advanced Non-Small Cell Lung CancerCompletedNCT01966003Phase 3Results posted
- Effectiveness of a Preoperative Pulmonary Rehabilitation Program in Patients Awaiting Lung ResectionCompletedNCT01963923Not applicableResults posted
- Study of Cryoablation for Metastatic Lung TumorsCompletedNCT01957787Not applicableResults posted
- Denosumab in Combination With Chemotherapy as First-line Treatment of Metastatic Non-small Cell Lung CancerCompletedNCT01951586Phase 2Results posted
- A Clinical Study in Three-arm of Lurbinectedin (PM01183) Alone or in Combination With Gemcitabine and a Control Arm With Docetaxel as Second Line Treatment in Non-Small Cell Lung Cancer (NSCLC) PatientsCompletedNCT01951157Phase 2Results posted
- Nintedanib in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Up to Two Previous Chemotherapy RegimensCompletedNCT01948141Phase 2Results posted
- Phase II Safety and Efficacy Study of Crizotinib in East Asian Patients With ROS1 Positive, ALK Negative Advanced NSCLCCompletedNCT01945021Phase 2Results posted
- Study of Carfilzomib With Irinotecan in Irinotecan-Sensitive Malignancies and Small Cell Lung Cancer PatientsCompletedNCT01941316Phase 1/2Results posted
- Azacitidine and Entinostat Before Chemotherapy in Treating Patients With Advanced Non-small Cell Lung CancerTerminatedNCT01935947Phase 2Results posted
- Study of Ponatinib in Patients With Lung Cancer Preselected Using Different Candidate Predictive BiomarkersCompletedNCT01935336Phase 2Results posted
- Improving Communication About Serious IllnessCompletedNCT01933789Not applicableResults posted
- Phase II Anti-PD1 Epigenetic Therapy Study in NSCLC.CompletedNCT01928576Phase 2Results posted
- Dacomitinib + Pemetrexed for Patients With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC)TerminatedNCT01918761Phase 1Results posted
- Study of Two Doses of Pembrolizumab (MK-3475) Versus Docetaxel in Previously Treated Participants With Non-Small Cell Lung Cancer (MK-3475-010/KEYNOTE-010)CompletedNCT01905657Phase 2/3Results posted
- A Randomized Phase 2 Study of Atezolizumab (an Engineered Anti-PDL1 Antibody) Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum Therapy - "POPLAR"CompletedNCT01903993Phase 2Results posted
- Rovalpituzumab Tesirine (SC16LD6.5) in Recurrent Small Cell Lung CancerCompletedNCT01901653Phase 1/2Results posted
- Supportive Care for Patients Newly Diagnosed With Lung CancerCompletedNCT01883986Not applicableResults posted
- Lisinopril in Reducing Shortness of Breath Caused by Radiation Therapy in Patients With Lung CancerCompletedNCT01880528Phase 2Results posted
- A Study of Alectinib (CH5424802/RO5424802) in Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NSCLC)CompletedNCT01871805Phase 1/2Results posted
- Cabozantinib-S-Malate and Erlotinib Hydrochloride in Treating Patients With Previously Treated Metastatic Non-Small Cell Lung CancerCompletedNCT01866410Phase 2Results posted
- Tivantinib in Treating Patients With Previously Treated Malignant MesotheliomaTerminatedNCT01861301Phase 2Results posted
- Neoadjuvant Chemo for Non-metastatic Non-small Cell Lung CancerTerminatedNCT01860040Phase 2Results posted
- A Phase 1b/2 Study of OMP-59R5 (Tarextumab) in Combination With Etoposide and Platinum TherapyTerminatedNCT01859741Phase 1/2Results posted
- A Study Of Dacomitinib (PF-00299804) In Patients With Advanced Non-Small Cell Lung CancerCompletedNCT01858389Phase 2Results posted
- Erlotinib Hydrochloride Before Surgery in Treating Patients With Stage III Non-Small Cell Lung CancerTerminatedNCT01857271Phase 2Results posted
- A Study to Demonstrate the Benefit of a New Kind of Anti-cancer Treatment [PReferentially Expressed Antigen of MElanoma (PRAME) Immunotherapy] for Patients With Non-Small Cell Lung Cancer (NSCLC), After Removal of Their TumorCompletedNCT01853878Phase 2Results posted
- Percutaneous Image Guided Video-Assisted Thoracic Surgery (VATS) Resection of Lung LesionsCompletedNCT01847209Phase 2Results posted
- A Study of Atezolizumab in Participants With Programmed Death-Ligand 1 (PD-L1) Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) [FIR]CompletedNCT01846416Phase 2Results posted
- Assessment of the Effectiveness of Local Ablathermy Radio Frequency Bronchial Tumors PrimitiveCompletedNCT01841060Not applicableResults posted
- An Observational Study of Tarceva (Erlotinib) in Participants With Locally Advanced or Metastatic Adenocarcinoma Non-Small Cell Lung Cancer (ELEMENT)CompletedNCT01836133Results posted
- Bortezomib in KRAS-Mutant Non-Small Cell Lung Cancer in Never Smokers or Those With KRAS G12DCompletedNCT01833143Phase 2Results posted
- Phase I Study of Lurbinectedin (PM01183) in Combination With Paclitaxel, With or Without Bevacizumab, in Selected Advanced Solid TumorsCompletedNCT01831089Phase 1Results posted
- Phase II Trial of Carboplatin and Pemetrexed +/- OGX-427 in Untreated Stage IV Non-Squamous-Non-Small-Cell Lung CancerCompletedNCT01829113Phase 2Results posted
- LDK378 Versus Chemotherapy in ALK Rearranged (ALK Positive) Patients Previously Treated With Chemotherapy (Platinum Doublet) and CrizotinibCompletedNCT01828112Phase 3Results posted
- LDK378 Versus Chemotherapy in Previously Untreated Patients With ALK Rearranged Non-small Cell Lung CancerCompletedNCT01828099Phase 3Results posted
- Neratinib With and Without Temsirolimus for Patients With HER2 Activating Mutations in Non-Small Cell Lung CancerCompletedNCT01827267Phase 2Results posted
- Docetaxel With or Without FGFR Inhibitor AZD4547 in Treating Patients With Recurrent Non-Small Cell Lung CancerCompletedNCT01824901Phase 1/2Results posted
- Erlotinib Hydrochloride or Crizotinib and Chemoradiation Therapy in Treating Patients With Stage III Non-small Cell Lung CancerTerminatedNCT01822496Phase 2Results posted
- Evaluation of Circulating T Cells and Tumor Infiltrating Lymphocytes (TILs) During / After Pre-Surgery Chemotherapy in Non-Small Cell Lung Cancer (NSCLC)CompletedNCT01820754Phase 2Results posted
- Ponatinib in Advanced NSCLC w/ RET TranslocationsCompletedNCT01813734Phase 2Results posted
- Assess Safety & Efficacy of Selumetinib When Given in Combination With Standard First Line Treatment for Advanced Non-small Cell Lung CancerCompletedNCT01809210Phase 1Results posted
- 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis TherapyCompletedNCT01806675Phase 1/2Results posted
- Topotecan Hydrochloride or Cyclodextrin-Based Polymer-Camptothecin CRLX101 in Treating Patients With Recurrent Small Cell Lung CancerTerminatedNCT01803269Phase 2Results posted
- Feasibility Study of Enhanced MRI for Early Stage Non Small Cell Lung Cancer (NSCLC)TerminatedNCT01799135Not applicableResults posted
- A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLCTerminatedNCT01798485Phase 3Results posted
- Safety of LEAD Radiotherapy Plus Chemoradiation in Patients With Bulky Stage III Non-Small Cell Lung CancerTerminatedNCT01797471Not applicableResults posted
- Hippocampal Prophylactic Cranial Irradiation for Small Cell Lung CancerCompletedNCT01797159Not applicableResults posted
- A Study of Gemcitabine-Cisplatin Chemotherapy Plus Necitumumab in the First-Line Treatment of Participants With Squamous Lung CancerCompletedNCT01788566Phase 2Results posted
- The Symptom Experience Study in Persons With Non-Small Cell Lung CancerCompletedNCT01786187Phase 1/2Results posted
- Analgesic Efficacy of Intravenous Acetaminophen After Video-assisted Thoracic SurgeryCompletedNCT01783236Phase 4Results posted
- ARCHER1050: A Study of Dacomitinib vs. Gefitinib in 1st-Line Treatment Of Advanced NSCLC.CompletedNCT01774721Phase 3Results posted
- Etirinotecan Pegol (NKTR-102) in NSCLCCompletedNCT01773109Phase 2Results posted
- A Study of Necitumumab and Chemotherapy in Participants With Stage IV Squamous Non-Small Cell Lung CancerCompletedNCT01769391Phase 2Results posted
- A Study of Necitumumab in the First-Line Treatment of Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC)CompletedNCT01763788Phase 1/2Results posted
- A Safety and Efficacy Study of BCD-021 With Paclitaxel and Carboplatin Compared to Avastin With Paclitaxel and Carboplatin in Non-Small Cell Lung CancerCompletedNCT01763645Phase 3Results posted
- Phase I/II NabPaclitaxel, Paclitaxel&Carboplatin w RTX Followed by Consolidation in Patients w Favorable Prognosis Inoperable Stage IIIA/B NSCLCCompletedNCT01757288Phase 1/2Results posted
- Radical Resection Vs. Ablative Stereotactic Radiotherapy in Patients With Operable Stage I NSCLCActive, not recruitingNCT01753414Phase 2Results posted
- AUY922 for Advanced ALK-positive NSCLCCompletedNCT01752400Phase 2Results posted
- A Randomized Phase II Study of SUBATM-itraconazole in Patients With Untreated Squamous NSCLC.TerminatedNCT01752023Phase 2Results posted
- Assess Efficacy and Safety of AZD6244 in Combination With Docetaxel in Patients Receiving Second Line Non Small Cell Lung Cancer Treatment.CompletedNCT01750281Phase 2Results posted
- Surgery and/or Radiation Therapy or Standard Therapy and/or Clinical Observation in Treating Patients With Previously Treated Stage IV Non-small Cell Lung CancerCompletedNCT01725165Phase 2Results posted
- Study of Nivolumab (BMS-936558) in Patients With Advanced or Metastatic Squamous Cell Nonsmall-cell Lung Cancer Who Have Received At Least 2 Prior Systemic RegimensCompletedNCT01721759Phase 2Results posted
- Phase 2a Desipramine in Small Cell Lung Cancer and Other High-Grade Neuroendocrine TumorsTerminatedNCT01719861Phase 2Results posted
- Metformin as a Chemoprevention Agent in Non-small Cell Lung CancerTerminatedNCT01717482Phase 2Results posted
- A Study of Docetaxel and Ramucirumab Versus Docetaxel and Placebo in the Treatment of Stage IV Non-Small Cell Lung CancerCompletedNCT01703091Phase 2Results posted
- Single Arm on the Tolerability of Weekly Nab-paclitaxelCompletedNCT01702844Phase 2Results posted
- Screening for Lung Cancer in Older Patients (PLCO Screening Trial)Active, not recruitingNCT01696968Not applicableResults posted
- Serum Free Fatty Acid Metabolite Biomarkers of Lung CancerCompletedNCT01692951Results posted
- LDK378 in Crizotinib naïve Adult Patients With ALK-activated Non-small Cell Lung CancerCompletedNCT01685138Phase 2Results posted
- LDK378 in Adult Patients With ALK-activated NSCLC Previously Treated With Chemotherapy and CrizotinibCompletedNCT01685060Phase 2Results posted
- Study of Dovitinib and Biomarkers in Advanced Non-Small Cell Lung Cancer or Advanced Colorectal CancerCompletedNCT01676714Phase 2Results posted
- Study of BMS-936558 (Nivolumab) Compared to Docetaxel in Previously Treated Metastatic Non-squamous NSCLCCompletedNCT01673867Phase 3Results posted
- Home Telemonitoring for Patients With Lung CancerCompletedNCT01670539Not applicableResults posted
- A Study of Erlotinib in Participants With Locally Advanced or Metastatic Non-Small Cell Lung CancerCompletedNCT01667562Phase 3Results posted
- Clinicopathological Features of NSCLC Patients Associated With the Chromosome 2p (EML4-ALK)CompletedNCT01662635Results posted
- Intrapleural Bevacizumab and Cisplatin Therapy for Malignant Pleural Effusion Caused by Non-small Cell Lung CancerCompletedNCT01661790Phase 3Results posted
- 5-Fluorouracil Followed by Interferon-alfa-2b in Previously-treated Metastatic Gastrointestinal, Kidney, or Lung CancerCompletedNCT01658813Phase 2Results posted
- Comparison of Veliparib and Whole Brain Radiation Therapy (WBRT) Versus Placebo and WBRT in Adults With Brain Metastases From Non-Small Cell Lung CancerCompletedNCT01657799Phase 2Results posted
- Stereotactic Body Radiation Therapy in Stage II/III Non Small Cell Lung CancerCompletedNCT01657617Not applicableResults posted
- Stereotactic Body Radiation for Consolidation After Standard Chemoradiation for Stage 3 Lung CancerCompletedNCT01656460Not applicableResults posted
- Modulation of Autophagy in Patients With Advanced/Recurrent Non-small Cell Lung Cancer - Phase IICompletedNCT01649947Phase 2Results posted